CA9 and non-small cell lung carcinoma: In conclusion, our findings identify CAIX-driven metabolic reprogramming as a central mechanism of immune evasion in NSCLC and demonstrate that pharmacologic modulation with 4Mu mitigates hypoxia-induced acidosis, remodels the TME, and synergizes with PD-1 blockade to obtain an antitumor effect.